Mia's Feed
Medical News & Research

Blood Protein HMGB1 Identified as Key Player in Systemic Aging Transmission

Blood Protein HMGB1 Identified as Key Player in Systemic Aging Transmission

Share this article

A pioneering study reveals that the blood protein HMGB1 plays a crucial role in spreading aging signals across the body, offering new possibilities for anti-aging therapies.

2 min read

Recent research from Korea University College of Medicine has uncovered a groundbreaking mechanism by which cellular aging may spread throughout the body via the bloodstream. The study highlights the role of a blood protein called HMGB1—specifically its redox-sensitive form, ReHMGB1—in promoting systemic senescence, which is a hallmark of aging.

Senescent cells, which accumulate with age, secrete various pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP). These factors impair tissue regeneration and contribute to tissue dysfunction. Although the local effects of senescent cells are well-known, how aging signals propagate across different tissues was previously unclear.

The research team demonstrated that ReHMGB1 circulates freely in the blood and induces aging features in distant tissues. Laboratory experiments with human cells showed that ReHMGB1 triggers senescence markers, such as p21 and p16, and promotes SASP factor expression. In mouse models, systemic administration of ReHMGB1 resulted in increased tissue aging signs and reduced muscle function.

Importantly, the study found that neutralizing HMGB1 with specific antibodies in middle-aged mice reduced senescence markers and improved muscle regeneration and physical performance. This suggests that targeting extracellular HMGB1 may offer a promising therapeutic strategy to combat age-related tissue decline.

Professor Ok Hee Jeon explained that aging signals are not confined to local cells but can be transmitted systemically through the bloodstream, with ReHMGB1 serving as a key driver. Interrupting this pathway could potentially restore tissue regenerative capacity and mitigate aging effects.

This innovative research opens new avenues for developing anti-aging therapies that focus on systemic factors like HMGB1. Collaborations with experts in aging biology, including Professors Irina Conboy and Christopher Wiley, underpin the significance of these findings for future medical applications.

Source: https://medicalxpress.com/news/2025-06-blood-protein-hmgb1-aging-body.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Early Colonoscopy Screening at Age 45 Shows Similar Neoplasia Detection Rates as Older Adults, Supporting New Guidelines

New research supports lowering the age for colonoscopy screenings to 45, showing detection rates similar to older adults and bolstering updated guidelines for colorectal cancer prevention.

Innovative Breathalyzer Technology Aims to Transform Diabetes Monitoring

A new non-invasive breathalyzer device developed by Indiana University offers a promising way to monitor blood sugar levels in diabetics more comfortably and accurately, potentially transforming diabetes management and reducing health risks.

Combination of Ivonescimab and Chemotherapy Enhances Progression-Free Survival in EGFR-Positive NSCLC Patients

A groundbreaking Phase III trial shows that combining ivonescimab with chemotherapy significantly prolongs progression-free survival in patients with EGFR-mutant NSCLC, including those with brain metastases, offering new hope for improved lung cancer treatment.